Literature DB >> 20033642

Expression of cDNAs in human Natural Killer cell lines by retroviral transduction.

S M Shahjahan Miah1, Kerry S Campbell.   

Abstract

Human NK-like cell lines are difficult to transfect using standard mammalian expression vectors and conventional transfection protocols, but they are susceptible to retroviral transduction as a means to introduce cDNAs. Our laboratory has exploited this technique to study a number of receptors in human NK cell lines. The method utilizes a bicistronic retroviral vector that co-expresses either drug resistance or enhanced green fluorescent protein (EGFP) in parallel with the gene of interest. After a single infection with recombinant retrovirus, transduced NK cells can be sorted for expression of EGFP or the transduced cell surface marker. Alternatively, cells expressing the transduced cDNAs can be selected for by treatment with neomycin, puromycin, or hygromycin. Using this method, the sorted/selected cells uniformly express the gene of interest and the expression is stable for many weeks of culture.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20033642      PMCID: PMC2798139          DOI: 10.1007/978-1-60761-362-6_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.

Authors:  G B Cohen; R T Gandhi; D M Davis; O Mandelboim; B K Chen; J L Strominger; D Baltimore
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

2.  SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.

Authors:  Sei-ichi Yusa; Tracey L Catina; Kerry S Campbell
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

3.  KIR2DL4 differentially signals downstream functions in human NK cells through distinct structural modules.

Authors:  S M Shahjahan Miah; Tracey L Hughes; Kerry S Campbell
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

4.  KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production.

Authors:  Akiko Kikuchi-Maki; Sei-ichi Yusa; Tracey L Catina; Kerry S Campbell
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

5.  Protein kinase C regulates expression and function of inhibitory killer cell Ig-like receptors in NK cells.

Authors:  Diana A Alvarez-Arias; Kerry S Campbell
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

6.  KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).

Authors:  Sei-ichi Yusa; Tracey L Catina; Kerry S Campbell
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

7.  Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo.

Authors:  S Nagashima; R Mailliard; Y Kashii; T E Reichert; R B Herberman; P Robbins; T L Whiteside
Journal:  Blood       Date:  1998-05-15       Impact factor: 25.476

  7 in total
  6 in total

1.  Ubiquitylation of an internalized killer cell Ig-like receptor by Triad3A disrupts sustained NF-κB signaling.

Authors:  S M Shahjahan Miah; Amanda K Purdy; Nicholas B Rodin; Alexander W MacFarlane; Jennifer Oshinsky; Diana A Alvarez-Arias; Kerry S Campbell
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

2.  Integrins Influence the Size and Dynamics of Signaling Microclusters in a Pyk2-dependent Manner.

Authors:  Maria Steblyanko; Nadia Anikeeva; Kerry S Campbell; James H Keen; Yuri Sykulev
Journal:  J Biol Chem       Date:  2015-03-16       Impact factor: 5.157

3.  The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanisms.

Authors:  Tatiana Pazina; Ashley M James; Alexander W MacFarlane; Natalie A Bezman; Karla A Henning; Christine Bee; Robert F Graziano; Michael D Robbins; Adam D Cohen; Kerry S Campbell
Journal:  Oncoimmunology       Date:  2017-06-16       Impact factor: 8.110

4.  Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma.

Authors:  Tatiana Pazina; Ashley M James; Kimberly B Colby; Yibin Yang; Andrew Gale; Amy Jhatakia; Alper Y Kearney; Robert F Graziano; Natalie A Bezman; Michael D Robbins; Adam D Cohen; Kerry S Campbell
Journal:  Cancer Immunol Res       Date:  2019-08-20       Impact factor: 11.151

5.  Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity.

Authors:  Nadia Anikeeva; Maria Steblyanko; Svetlana Fayngerts; Natalya Kopylova; Deborah J Marshall; Gordon D Powers; Takami Sato; Kerry S Campbell; Yuri Sykulev
Journal:  Eur J Immunol       Date:  2014-06-05       Impact factor: 5.532

6.  Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody.

Authors:  Ying Chen; Fengtao You; Licui Jiang; Jialu Li; Xuejun Zhu; Yangyi Bao; Xiang Sun; Xiaowen Tang; Huimin Meng; Gangli An; Bozhen Zhang; Lin Yang
Journal:  Oncotarget       Date:  2017-06-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.